Merger: absorbed by MULTIPHARMA
Dissolution of the company · Dissolved without liquidation · Discharge granted to Hidden nameVisible after signing in · General meeting of 17-12-2014 · Gazette deed
Merger proposal: to be absorbed by MULTIPHARMA
Gazette deed
Name after signing inVisible after signing in (chair) and Name hiddenVisible after signing in (managing director) appointed
Board meeting of 16-06-2014 · Gazette deed
Registered office moved to Brussels
The registered office moved to Lenniksebaan 900 te 1070 Brussel · Hidden nameVisible after signing in (managing director), Name after signing inVisible after signing in and Name hiddenVisible after signing in resign · Hidden nameVisible after signing in, Name after signing inVisible after signing in, Name hiddenVisible after signing in and Hidden nameVisible after signing in (statutory auditor) appointed · General meeting of 16-06-2014 · Gazette deed
Absorbed by MULTIPHARMAmerger by absorption, October 2014
Activity
“De vennootschap heeft tot doel het voeren van alle activiteiten die normaal behoren tot…” (deed in Dutch)From the articles, 5 activitiesNo NACE code in the KBO
DAMO had an average of 2.7 full-time equivalents in financial year 2013, according to the filed annual accounts.Financials
What is the turnover of DAMO?
The turnover in financial year 2013 is about €740,000. This figure is estimated from the gross margin of €311,097 and 2,137 comparable companies of the same size. It probably lies between €440,000 and €1.3m. It is a rough estimate. In financial year 2011 turnover was €1.7m.
Is DAMO profitable?
In financial year 2013, DAMO made a profit of €111,683.
Where can I find the annual accounts of DAMO?
DAMO filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2013.